Collegium Pharmaceutical, Inc. (COLL)
48.86
+1.83
(+3.89%)
USD |
NASDAQ |
Dec 10, 16:00
48.83
-0.03
(-0.06%)
After-Hours: 20:00
Collegium Pharmaceutical Total Liabilities (Quarterly): 1.333B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 131.36M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Altimmune, Inc. | 32.85M |
| Vertex Pharmaceuticals, Inc. | 7.544B |
| Viking Therapeutics, Inc. | 26.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.607B |
| Shareholders Equity (Quarterly) | 274.81M |
| Debt to Equity Ratio | 3.407 |
| Current Ratio | 1.355 |
| Net Debt Paydown Yield | -6.82% |